chr12-55726197-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001780.6(CD63):c.491G>A(p.Arg164Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,613,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001780.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD63 | NM_001780.6 | c.491G>A | p.Arg164Gln | missense_variant | 6/8 | ENST00000257857.9 | NP_001771.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD63 | ENST00000257857.9 | c.491G>A | p.Arg164Gln | missense_variant | 6/8 | 1 | NM_001780.6 | ENSP00000257857.4 | ||
CD63 | ENST00000552067.5 | c.212G>A | p.Arg71Gln | missense_variant | 4/6 | 5 | ENSP00000449684.1 | |||
CD63 | ENST00000550050.5 | n.*157G>A | non_coding_transcript_exon_variant | 6/8 | 5 | ENSP00000449435.1 | ||||
CD63 | ENST00000550050.5 | n.*157G>A | 3_prime_UTR_variant | 6/8 | 5 | ENSP00000449435.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152030Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251472Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135916
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461814Hom.: 0 Cov.: 32 AF XY: 0.0000303 AC XY: 22AN XY: 727208
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152030Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74278
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2024 | The c.491G>A (p.R164Q) alteration is located in exon 6 (coding exon 5) of the CD63 gene. This alteration results from a G to A substitution at nucleotide position 491, causing the arginine (R) at amino acid position 164 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at